Skip to main content
Raphas Co., Ltd. logo

Raphas Co., Ltd. — Investor Relations & Filings

Ticker · 214260 ISIN · KR7214260002 KO Manufacturing
Open in API
Filings indexed 325 across all filing types
Latest filing 2023-03-07 AGM Information
Country KR South Korea
Listing KO 214260

About Raphas Co., Ltd.

https://www.raphas.com/

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for RAPHAS Co., Ltd. It includes the meeting agenda, voting procedures (electronic voting), and management information regarding the 17th Annual General Meeting. While it contains some financial data, it is explicitly labeled as 'pre-audit' (감사전 재무제표) and serves as the official notice for shareholders to attend the meeting. According to the filing definitions, materials shared for the AGM, including the notice and agenda, fall under the AGM-R category.
2023-03-07 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for the company 'Raphas' (주식회사 라파스). It contains the meeting agenda, details on voting procedures, and management information (such as board activities and business overview) typically included in proxy materials for an AGM. This document serves as the official notice and information statement for shareholders to prepare for the meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-06 Korean
의결권대리행사권유참고서류
AGM Information Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often associated with the DART system) used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting, the agenda, and proxy voting procedures. While it includes financial statements, these are provided as part of the proxy solicitation materials for the AGM, not as a standalone Annual Report or 10-K. Therefore, it is classified as AGM-R.
2023-03-06 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Report of Reason for Holding a General Meeting of Shareholders on a Concentrated Date'. It explains why the company (Raphas) scheduled its AGM on a date that coincides with many other companies, citing audit schedules and financial reporting timelines. Since this is a specific regulatory disclosure regarding meeting logistics and does not fit into the other categories like AGM-R (presentation materials) or PSI (proxy solicitation), it is classified as a general regulatory filing.
2023-03-06 Korean
기타경영사항(자율공시)('마이크로니들 파티클 및 마이크로니들 파티클의 제작방법' 특허권 취득)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a patent ('특허권 취득') by the company Raphas. It details the patent name, registration date, and its application in manufacturing processes. Since this is a specific corporate announcement regarding business operations that does not fit into financial reporting, dividend announcements, or management changes, it falls under the general regulatory filing category.
2023-02-23 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (Laphas) regarding a significant change in financial structure (revenue or profit/loss change of 30% or more). This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report preliminary financial results or significant changes before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) and reasons for the change, it fits the definition of an Earnings Release (ER), which covers initial announcements of periodical financial results. FY 2022
2023-02-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.